The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development (R&D) organization that develops and delivers new treatments for neglected diseases that affect millions of the world’s poorest people.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
Since our inception, DNDi has delivered nine new treatments for people with sleeping sickness, visceral leishmaniasis, Chagas disease, paediatric HIV, hepatitis C, and malaria that have saved millions of lives. We now aim to deliver an additional 15-18 new treatments by 2028 – addressing R&D gaps for neglected tropical diseases and viral infections, including new pandemic-prone diseases (such as COVID19) and climate-sensitive diseases (such as Dengue) with a focus on the needs of patients in low- and middle-income countries.
With 250 employees of 37 nationalities located in nine offices on four continents, DNDi is committed to diversity, equity, and inclusion as essential parts of our culture and key drivers of our success. We encourage candidates of diverse profiles and backgrounds to apply.
The R&D organisation drive therapeutic innovation from the lab bench to the patient bedside. it develops DNDi’s portfolio of drug candidates from the onset (with the design of target product profiles) to the end point (enabling patients’ access to the new treatments). With members located in various DNDi offices worldwide, R&D teams are key enablers of DNDi’s virtual research model which relies on collaborative partnerships with industry and science partners worldwide, fully inclusive of LMICS clinicians and researchers. Projects are run by project leaders and team members regrouping needed expertise from all DNDI functions, beyond R&D.
The R&D organisation include three clusters of Diseases expert teams: NTD/Mycetoma and Leishmaniasis, NTD/Chagas-Filarial-HAT and Viral Diseases. Integrated Clinical Development Sciences (Drug Safety and Pharmacovigilance, Clinical Quality Assurance, Regulatory Sciences and Translational Sciences), Global Clinical Operations, R&D Portfolio and Planning, Discovery and Pharmaceutical Development teams complement the R&D expertise. Projects review, Science and strategy is managed by the Scientific Internal Review Committee (SIRC); The R&D Coordination team lead the R&D organisation for all other topics.
The Clinical Quality Assurance (CQA) Manager supports the Clinical Quality Management System to ensure:
Contribution
This role is accountable for managing smaller scale projects and/or parts of the projects led by upper level, or delivering quality output through expert services or people. This role adapts policies, approaches and models to emerging needs.
Quality Documents (QDs)
Training
Clinical Trial Support & Optimisation
Audits / Quality Reviews
Inspections (or external audits)
Risk Management
Additional /specific/projects responsibilities
The above list of responsibilities is not exhaustive, and you may be required to undertake other responsibilities appropriate to your grade. This job description may be subject to review. |
Reporting line
Interactions Works with o Disease/Cluster Programs within DNDi, o Translational Sciences department, o Drug Safety and Pharmacovigilance team, o Regulatory Sciences team, o Pharmaceutical Development, o Procurement, o Legal, o Operations function (Data Protection) o Regional Offices.
|
Job Requirements |
Skills and Attributes
R&D Technical Skills
|
Experience
Education
DNDi Leadership Competencies
DNDi has developed in 2017 a set of leadership competencies and identified behaviors that is referred to as standard for leaders and is aligned to DNDi’s values. The 6 major competency areas are the following:
Contextualised skillfulness
R&D Technical Skills
DNDi is committed to building a diverse, equitable and truly inclusive organisation. Our success and global reach are dependent upon our ability to encourage diversity and draw on the skills, understanding and experience of all our people. We particularly welcome applications from those who are underrepresented in at DNDi and across the sector, especially women, and including, but not limited to, black and minority ethnic candidates, and those with other protected characteristic.